As of the end of February, the net asset value per share of CH INV FIN GP was approximately HKD 0.73.
China Investment and Financing (01226) announced that the unaudited net asset value per share of the company's comprehensive assets as of February 28, 2026 is approximately HK$0.73.
CH INV FIN GP (01226) announced that as of February 28, 2026, the unaudited net asset value per share of the company's comprehensive assets is approximately 0.73 Hong Kong dollars.
Related Articles
In the first two months of the year, the total sales of property contracts in Central China (00832) decreased by 37.7% year-on-year to 9.8 billion yuan.
Jiangsu Hengrui Pharmaceuticals (01276): The application for marketing approval of Sucranolide insulin analog injection has been accepted by the National Medical Products Administration.
CICC (03908) plans to redeem "21 CICC Y2"
In the first two months of the year, the total sales of property contracts in Central China (00832) decreased by 37.7% year-on-year to 9.8 billion yuan.
Jiangsu Hengrui Pharmaceuticals (01276): The application for marketing approval of Sucranolide insulin analog injection has been accepted by the National Medical Products Administration.
CICC (03908) plans to redeem "21 CICC Y2"
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
